Agency Forms Undergoing Paperwork Reduction Act Review, 73286-73287 [2021-28032]
Download as PDF
<![CDATA[
73286
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
‘‘Varicella (Chickenpox) Vaccine: What
You Need to Know,’’ publication date August
6, 2021.
‘‘Your Child’s First Vaccines: What You
Need to Know,’’ publication date October 15,
2021.
With publication of this notice, by
March 31, 2022, all healthcare providers
must discontinue use of the previous
editions and provide copies of these
updated vaccine information materials
prior to immunization in conformance
with CDC Instructions for Use of
Vaccine Information Statements dated
October 15, 2021.
Dated: December 20, 2021.
Angela K. Oliver,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2021–27929 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0852]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Prevalence
Survey of Healthcare-Associated
Infections and Antimicrobial Use in
U.S. Acute Care Hospitals to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
13, 2021 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Prevalence Survey of HealthcareAssociated Infections and Antimicrobial
Use in U.S. Acute Care Hospitals (OMB
Control No. 0920–0852, Exp. 10/31/
2022)—Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated
infections (HAIs) and improving
antimicrobial use (AU) are CDC and
national priorities. An essential step in
reducing the occurrence of HAIs is to
accurately estimate the burden of these
infections in U.S. acute care hospitals
and to describe the types of HAIs and
causative pathogens. Periodic
assessments of the magnitude and types
of HAIs and AU occurring in all patient
populations within acute care hospitals
are needed to inform decisions by
policy makers and hospital infection
control personnel (ICP) regarding
appropriate targets and strategies for
HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four
prevalence surveys (i.e., pilot survey in
2009, limited-scale survey in 2010, and
two full-scale surveys in 2011 and 2015)
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
in partnership with the CDC’s Emerging
Infections Program (EIP) sites. Findings
from the most recent survey showed a
reduction in the percentage of patients
with healthcare-associated infections
compared with 2011. We granted
approval from OMB to conduct the fifth
survey in 2020, but due to the COVID–
19 pandemic the survey was postponed
to 2023.
Minor adjustments to data collection
instruments since the previous 2019
OMB approval have been made. These
adjustments were made to enhance
future analyses and utility of the survey
data. These changes are non-substantive
and are not expected to increase the
public reporting burden. An extension
of the prevalence survey’s existing OMB
approval is sought to allow a repeat HAI
and AU Prevalence Survey to be
performed in 2023. A repeat survey will
allow assessment of changes in HAI and
AU prevalence, pathogen distribution,
and quality of antimicrobial prescribing.
These data will also allow CDC and its
partners to continue to monitor HAI and
AU trends, to measure progress in
meeting national targets, and to further
refine prevention strategies.
In the 2023 survey, data collection
will occur within acute care general
hospitals of varying size in each of the
10 EIP sites (i.e., CA, CO, CT, GA, MD,
MN, NM, NY, OR, & TN). Infection
Control Personnel in participating
hospitals may assist EIP site personnel
in collecting demographic and limited
clinical data from the electronic or
paper-based medical records of a sample
of randomly selected patients on a
single day in 2023. Patients will not be
interviewed, and no direct interaction
with patients will occur. Hospital and
patient-level data will be collected using
unique identification codes. EIP site
personnel will submit hospital and
patient-level data to CDC using a secure
data management system.
Based on experiences from previous
surveys, the time required to complete
the Healthcare Facility Assessment
Form (HFA) and Patient Information
Form (PIF) is estimated to be 45 and 17
minutes, respectively. To conduct the
full-scale survey in a three-year
approval period, 100 hospital
respondents will complete the HFA
once, and the PIF on average 63 times
per year. The total estimated annualized
public burden is 1,860 hours, which
represents no change from the 2019
OMB approval.
To assess changes in HAIs and AU
over time, EIP sites will seek
participation from the same hospitals
that participated in prior surveys. These
hospitals were originally selected for
participation using a stratified random
E:\FR\FM\27DEN1.SGM
27DEN1
73287
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
sampling scheme based on the number
of staffed acute care beds (i.e., small:
<150 staffed beds; medium: 151–399
staffed beds; large: >400 staffed beds).
Each site will also have the option to
recruit additional hospitals for a total of
up to 30 in each site. As in previous
surveys, hospital participation will
remain voluntary. Within each
participating hospital, EIP site
personnel will establish patient sample
size targets based on the number of
staffed acute care beds (e.g., up to 75
patients in small hospitals, 75 patients
in medium hospitals, and 100 patients
in large hospitals).
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Hospital Staff (Infection Preventionist) ..................................
HFA .........................................
PIF ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–28032 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0017]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Application
for Training’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 26,
2021 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice, and provided a
standard response. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Application for Training (OMB
Control No. 0920–0017, Exp. 4/30/
2022)—Revision—Center for
Surveillance, Epidemiology, and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of CDC’s Division of
Scientific Education and Professional
Development (DSEPD) is to support the
development of a competent,
sustainable, and empowered public
health workforce. Professionals in
public health, epidemiology, medicine,
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
100
100
Number of
responses per
respondent
1
63
Average
burden per
response
(in hours)
45/60
17/60
economics, information science,
veterinary medicine, nursing, public
policy, and other related professions
seek professional development
opportunities (both accredited and
nonaccredited) through two CDC
learning management systems. These
two learning management systems are
Training and Continuing Education
Online (TCEO) (for accredited courses)
and CDC TRAIN (for nonaccredited
courses developed by CDC programs,
grantees, and other funded partners).
These two systems allow for the public
health workforce to broaden their
knowledge and skills to improve the
science and practice of public health for
domestic and international impact. Both
systems currently involve related, but
separate, information collection tools
and information technology platforms.
The CDC seeks approval to implement
changes as follows:
1. In TCEO, two additional
accreditation types will be added as
options a learner can select, to allow for
master certified health education
specialists and physician assistants to
earn continuing education. Additional
text is added to clarify what is requested
for the CPE (Continuing Pharmacy
Education) ID number.
2. CDC TRAIN is added as a data
collection platform. The addition of
CDC TRAIN to this request also
supports the eventual merger of the two
learning systems, a process that is
underway and described further below.
Adding CDC TRAIN to this revision also
would allow CDC programs to collect
standardized post-course evaluation
data for program improvement, similar
to what is done currently in TCEO (see
#3).
3. The two standard training
evaluation tools in CDC TRAIN are
added to evaluate a training’s
effectiveness (learning transfer and
quality training) as well as its
promotion, delivery, and learner
satisfaction at two time points
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Pages 73286-73287]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28032]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0852]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Prevalence Survey of Healthcare-Associated
Infections and Antimicrobial Use in U.S. Acute Care Hospitals to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on August 13, 2021 to obtain
comments from the public and affected agencies. CDC received one non-
substantive comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 10/31/2022)--Extension--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and improving
antimicrobial use (AU) are CDC and national priorities. An essential
step in reducing the occurrence of HAIs is to accurately estimate the
burden of these infections in U.S. acute care hospitals and to describe
the types of HAIs and causative pathogens. Periodic assessments of the
magnitude and types of HAIs and AU occurring in all patient populations
within acute care hospitals are needed to inform decisions by policy
makers and hospital infection control personnel (ICP) regarding
appropriate targets and strategies for HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four prevalence surveys (i.e., pilot
survey in 2009, limited-scale survey in 2010, and two full-scale
surveys in 2011 and 2015) in partnership with the CDC's Emerging
Infections Program (EIP) sites. Findings from the most recent survey
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011. We granted approval from OMB
to conduct the fifth survey in 2020, but due to the COVID-19 pandemic
the survey was postponed to 2023.
Minor adjustments to data collection instruments since the previous
2019 OMB approval have been made. These adjustments were made to
enhance future analyses and utility of the survey data. These changes
are non-substantive and are not expected to increase the public
reporting burden. An extension of the prevalence survey's existing OMB
approval is sought to allow a repeat HAI and AU Prevalence Survey to be
performed in 2023. A repeat survey will allow assessment of changes in
HAI and AU prevalence, pathogen distribution, and quality of
antimicrobial prescribing. These data will also allow CDC and its
partners to continue to monitor HAI and AU trends, to measure progress
in meeting national targets, and to further refine prevention
strategies.
In the 2023 survey, data collection will occur within acute care
general hospitals of varying size in each of the 10 EIP sites (i.e.,
CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN). Infection Control Personnel
in participating hospitals may assist EIP site personnel in collecting
demographic and limited clinical data from the electronic or paper-
based medical records of a sample of randomly selected patients on a
single day in 2023. Patients will not be interviewed, and no direct
interaction with patients will occur. Hospital and patient-level data
will be collected using unique identification codes. EIP site personnel
will submit hospital and patient-level data to CDC using a secure data
management system.
Based on experiences from previous surveys, the time required to
complete the Healthcare Facility Assessment Form (HFA) and Patient
Information Form (PIF) is estimated to be 45 and 17 minutes,
respectively. To conduct the full-scale survey in a three-year approval
period, 100 hospital respondents will complete the HFA once, and the
PIF on average 63 times per year. The total estimated annualized public
burden is 1,860 hours, which represents no change from the 2019 OMB
approval.
To assess changes in HAIs and AU over time, EIP sites will seek
participation from the same hospitals that participated in prior
surveys. These hospitals were originally selected for participation
using a stratified random
[[Page 73287]]
sampling scheme based on the number of staffed acute care beds (i.e.,
small: <150 staffed beds; medium: 151-399 staffed beds; large: >400
staffed beds). Each site will also have the option to recruit
additional hospitals for a total of up to 30 in each site. As in
previous surveys, hospital participation will remain voluntary. Within
each participating hospital, EIP site personnel will establish patient
sample size targets based on the number of staffed acute care beds
(e.g., up to 75 patients in small hospitals, 75 patients in medium
hospitals, and 100 patients in large hospitals).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (Infection HFA..................... 100 1 45/60
Preventionist).
PIF..................... 100 63 17/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-28032 Filed 12-23-21; 8:45 am]
BILLING CODE 4163-18-P
